Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.


BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

16 September 2021

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.

BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

19 August 2021

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.

BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

10 May 2021

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.

BWXT Expands Technical Fellows Program

27 April 2021

(LYNCHBURG, Va. – April 27, 2021) – BWX Technologies, Inc. (NYSE: BWXT) has expanded its existing technical fellows initiative by selecting 25 additional employees for the program in recognition of their scientific and engineering accomplishments at the company.

BWXT Announces $2.2 Billion in Contracts for Naval Nuclear Reactor Components and Fuel

20 April 2021

(LYNCHBURG, Va. – April 20, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.2 billion, including future-year options, for the manufacture of naval nuclear reactor components and fuel.

BWXT Awarded $690 Million Extension for Environmental Management Work at Portsmouth

06 April 2021

(LYNCHBURG, Va. – April 6, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract extension, valued at up to $690 million including options, from the U.S. Department of Energy (DOE) for environmental management work at Portsmouth Gaseous Diffusion Plant.

BWXT Awarded Additional Nuclear Thermal Propulsion Work for NASA

01 April 2021

(LYNCHBURG, Va. – April 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is continuing its groundbreaking Nuclear Thermal Propulsion (NTP) design, manufacturing development, and test support work for NASA. NTP is one of the technologies that is capable of propelling a spacecraft to Mars, and this contract continues BWXT’s work that began in 2017.

BWXT Awarded $28 Million Contract for Continued Mobile Microreactor Design

25 March 2021

(LYNCHBURG, Va. – March 25, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a $28 million, 12-month contract award from the Department of Defense’s (DoD) Strategic Capabilities Office (SCO) for the final design of a transportable microreactor prototype under the second phase of its Project Pele initiative.

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141